University of Texas: Testosterone Nasal Spray to Treat Anxiety Disorders
December 19, 2020
December 19, 2020
AUSTIN, Texas, Dec. 19 (TNSRes) -- The University of Texas issued the following news release:
A testosterone-containing nasal spray received its second U.S. patent and its first patent in Europe, making it the first testosterone therapy licensed to treat anxiety disorders.
Although testosterone therapy is most often marketed and prescribed to men suffering from "low T" -- testosterone deficiency or hypogonadism -- researchers with The University of Texas at Au . . .
A testosterone-containing nasal spray received its second U.S. patent and its first patent in Europe, making it the first testosterone therapy licensed to treat anxiety disorders.
Although testosterone therapy is most often marketed and prescribed to men suffering from "low T" -- testosterone deficiency or hypogonadism -- researchers with The University of Texas at Au . . .